Janux Therapeutics, Inc. (JANX) Net margin 2021–2025
Janux Therapeutics, Inc. (JANX) net profit margin by fiscal year — reported net income divided by reported revenue.
-1136.2%FY2025 · since FY2021: -898.3% → -1136.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1136.2% | -484.6 pp |
| FY2024 | -651.6% | +69.6 pp |
| FY2023 | -721.2% | +11.0 pp |
| FY2022 | -732.2% | +166.1 pp |
| FY2021 | -898.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More JANX financial trends
JANX RevenueJANX Net incomeJANX Gross profitJANX Gross marginJANX Operating incomeJANX Operating marginJANX Operating cash flowJANX Free cash flowJANX Capital expendituresJANX Return on equityJANX Stock buybacksJANX Dividends paidJANX Total assetsJANX Total liabilitiesJANX Shareholders’ equityJANX overview →